Le Lézard
Classified in: Health
Subject: AVO

GI society statement: UHC offers to trade GI prior auth for a poorly defined alternative


NORTH BETHESDA, Md. and BETHESDA, Md. and DOWNERS GROVE, Ill., May 26, 2023 /PRNewswire/ -- After weeks of being questioned by patients and GI providers about a new prior authorization policy planned to go into effect June 1, UnitedHealthcare requested a meeting today with the American College of Gastroenterology, American Gastroenterological Association and American Society for Gastrointestinal Endoscopy.

UHC offers to pause controversial GI prior auth policy in exchange for support of a poorly defined alternative.

The fact is that UHC has not been able to clearly articulate the need for such a sweeping prior authorization program. For weeks the GI societies have been asking UHC to share internal data that justifies prior authorization for 61 endoscopy codes, including low-volume codes.

UHC's stated purpose of today's meeting was to discuss delaying their GI prior authorization program in exchange for an "advance notification program," requiring GI practices and staff to gather detailed patient data prior to procedures and in preparation for a Gold Card program in 2024.

Unfortunately, what UHC verbally presented in our meeting was a poorly defined and complicated administrative process. The GI societies are not in a position to appropriately evaluate the UHC proposal with the limited information presented.

A pause in the June 1 launch of UHC's prior authorization policy requires the GI societies to publicly support this alternative proposal by early next week. Our patients' health is at stake and we cannot meet this unreasonable request.

The GI societies reaffirm our call on UnitedHealthcare to stop the GI prior authorization policy from going into effect June 1.

SOURCE American Gastroenterological Association


These press releases may also interest you

at 05:45
The Gross Law Firm issues the following notice to shareholders of bluebird bio, Inc. . Shareholders who purchased shares of BLUE...

at 05:44
According to the latest BCC Research study, the demand for Pharmacy Automation: Technologies and Global Markets is growing from $7.8 billion in 2023 to $12.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 10.2% from 2023...

at 05:05
Sun Nuclear, a Mirion Medical company, will feature new and enhanced solutions for better Quality Management at the ESTRO Annual Meeting, May 3-6, in Glasgow, Scotland. The Sun Nuclear booth (#930) will highlight demonstrations and insights on the...

at 04:32
According to the latest BCC...

at 03:05
In Q1 2024, LEO Pharma delivered a revenue growth of 13% in constant exchange rates (CER). The dermatology portfolio saw accelerated growth in revenue of 16%. The acquisition of TMB-001 to the treatment of congenital ichthyosis added a late-stage...

at 02:22
Hansa Biopharma AB (publ), ("Hansa" or the "Company") (STO: HNSA) today announced that the company's registered share capital and number of shares and votes have increased through the issue of 10,474,740 new ordinary shares on 12 April 2024, whereby...



News published on and distributed by: